Homology Medicines Added to the Russell 3000® and Russell 2000® Indexes
Homology Medicines Added to the Russell 3000® and Russell 2000® Indexes - Company Will Also Ring the Nasdaq Stock Market Opening Bell Today - |
[25-June-2018] |
BEDFORD, Mass., June 25, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that it has been added to the Russell 3000® Index and Russell 2000® Index effective after the market opens today. Homology's membership in the Russell US Indexes is determined primarily by objective, market-capitalization rankings and style attributes. Russell US Indexes are widely used by investment managers and institutional investors as the basis for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell US Indexes. In other news today, Homology announced that it will ring the Nasdaq stock market Opening Bell this morning, and a live stream of the event will be available at https://new.livestream.com/nasdaq/live. About Homology Medicines, Inc.
View original content with multimedia:http://www.prnewswire.com/news-releases/homology-medicines-added-to-the-russell-3000-and-russell-2000-indexes-300671229.html SOURCE Homology Medicines, Inc. | ||
Company Codes: NASDAQ-NMS:FIXX |
© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}